市場調查報告書
商品編碼
1479070
全球腔內縫合設備市場評估:依產品、組件、應用、最終用戶、地區、機會、預測(2017-2031)Endoluminal Suturing Devices Market Assessment, By Product, By Component, By Application, By End-User, By Region, Opportunities and Forecast, 2017-2031F |
全球腔內縫合器材市場規模預計將從 2023 年的 9,128 萬美元增至 2031 年的 1.9,638 億美元,在 2024-2031 年的預測期內複合年增長率為 10.05%。對非侵入性手術的日益偏好、胃腸道癌症盛行率的增加以及醫療部門的擴大支持了市場的擴張。
慢性病盛行率的增加是全球腔內縫合器材市場的主要趨勢之一。這一增長是由於腔內縫合裝置在胃腸手術、減肥手術、胃食道逆流、胸腔外科、泌尿外科手術等中發揮重要作用。在減重手術中,這些設備被用來執行各種手術,例如胃繞道術和胃套,以幫助患者透過減重來控制肥胖相關的併發症。人們對這些設備越來越青睞的部分原因可能是它們能夠以微創方式治療健康狀況、提供更快的康復、降低手術風險並提高患者的生活品質。
人們越來越關注提高醫療保健系統的效率和成本效益,這為市場提供了利潤豐厚的成長機會。腔內縫合裝置可以幫助醫療保健提供者優化資源,同時降低與長期住院相關的成本。胃腸道疾病患者數量的不斷增加,進一步增加了對腔內縫合器械的需求。根據2022年7月至2023年5月的問卷調查,海南省功能性胃腸病情為32%。加強醫療基礎設施投資的增加和人口的快速成長也是推高全球腔內縫合器材市場規模的主要因素。
對微創手術的日益青睞支持市場擴張
由於人們對微創手術相關各種好處的認識不斷增強,人們對微創手術的偏好日益增加,這對市場擴張產生了積極影響。微創手術可減少併發症、減少疼痛並縮短住院時間。這些儀器幫助外科醫生在解剖學上困難的位置和體腔內進行精確的縫合。該儀器提供的更高的可操作性和控制能力使外科醫生能夠獲得更好的手術結果。它還可以縮短康復時間、降低感染風險並提高患者滿意度。腔內縫合裝置還允許外科醫生在內部縫合組織,從而無需大切口。這將推動需求並對市場擴張產生積極影響。
技術進步推動全球腔內縫合器材市場
不斷增加的研究和開發有助於提高腔內縫合設備的功能性、易用性和精確度,正在推動市場成長。機器人技術的使用為外科醫生提供了靈巧而精確的動作,以及符合人體工學和直覺的操作。人們對手術過程中微創性的日益偏好,加上機器人技術的進步,正在支持靈活手術機器人的出現。此外,結合內視鏡檢查和螢光透視等影像技術可實現即時視覺化,從而改善縫合過程中的手術結果。技術進步支持開發具有數據管理和無線連接功能的先進腔內縫合設備,能夠即時監控手術指標和設備參數,從而為市場提供利潤豐厚的成長機會。
各主要市場參與者增加研發投資也支持使用先進技術的腔內縫合裝置的開發。2022 年,波士頓科學公司在浦那開設了最先進的研發中心。該中心提供內視鏡、泌尿科、心臟病學和神經調節等多個領域的專業知識。
北美佔有很大的市場佔有率
支持北美腔內縫合器械市場成長的因素包括成熟的醫療基礎設施、外科手術需求的不斷增長以及各種主要市場參與者的強勢佈局。該地區的市場成長也歸因於優惠報銷政策的推出和大量患者群體的可用性。此外,加拿大和美國等國家對微創手術的需求正在增加。微創手術可降低感染、出血、疤痕和恢復時間等風險。腔內縫合器械在此類手術中發揮重要作用,使外科醫生能夠透過較小的切口進行縫合。該地區肥胖治療數量的增加進一步支持了北美市場的擴張。美國代謝與減重手術協會American Society for Metabolic and Bariatric Surgery估計,2022 年進行的減重手術總數為 279,967 例。
本報告研究和分析了全球腔內縫合器材市場,提供市場規模和預測、市場動態以及主要參與者的現狀和前景。
Global endoluminal suturing devices market is projected to witness a CAGR of 10.05% during the forecast period 2024-2031, growing from USD 91.28 million in 2023 to USD 196.38 million in 2031F. The expansion of the market is supported by the increase in preference for non-invasive surgical procedures, growth in prevalence of gastrointestinal cancer, and the expansion of the healthcare sector.
The increasing prevalence of chronic diseases is one of the major global endoluminal suturing devices market trends. This increase is propelling the requirement for various efficient surgical solutions, including endoluminal suturing devices, as they play a crucial role in gastrointestinal surgeries, bariatric surgeries, gastroesophageal reflux disease, thoracic procedures, and urological procedures, among others. In bariatric surgery, these devices are deployed for performing different procedures, including gastric bypass and gastric sleeve, aiding patients in managing obesity-related comorbidities by achieving weight loss. The increased preference for these devices can also be attributed to their ability to treat the health condition in a minimally invasive manner, provide faster recovery and reduce surgical risks and improving the quality of life of the patient.
The rising emphasis on increasing the efficiency and cost-effectiveness of healthcare systems is providing lucrative growth opportunities for the market. Endoluminal suturing devices aid healthcare providers in reducing costs associated with extended hospital stays while allowing them to optimize resources. The growing number of cases of gastrointestinal disorders is further boosting the requirement for endoluminal suturing devices. According to a questionnaire survey conducted from July 2022 to May 2023, in Hainan, the prevalence of functional gastrointestinal diseases was 32%. The growing investments towards the enhancement of healthcare infrastructure and rapid population expansion are other major factors boosting the global endoluminal suturing devices market size.
Increasing Preference for Minimally Invasive Procedures Supports Market Expansion
The rising preference for minimally invasive procedures due to growing awareness about the various advantages associated with them is positively influencing the expansion of the market. Minimally invasive procedures are linked with fewer complications, less pain, and shorter hospitalizations. These devices aid surgeons in performing precise suturing in anatomically challenging locations and body cavities. The greater maneuverability and control offered by the devices further allow surgeons to achieve optimal surgical outcomes. The devices are also associated with faster recovery times, reduced risk of infection, and improved patient satisfaction. Endoluminal suturing devices also eliminate the requirement for large incisions by allowing surgeons to suture tissues internally, thus boosting their demand and positively influencing market expansion.
Technological Advancements Boost Global Endoluminal Suturing Devices Market
The increasing research and development efforts to support the enhancement of the functionality, ease of use, and precision offered by endoluminal suturing devices are driving the growth of the market. The utilization of robotic technology provides surgeons with dexterous and precise motions along with ergonomic and intuitive manipulation. The increased preference for minimal invasiveness during surgeries, coupled with technological advancements in robotics, has supported the emergence of flexible surgical robots. Additionally, the incorporation of imaging technologies, such as endoscopy and fluoroscopy, provides real-time visualization that improves procedural outcomes during the suturing process. Technological advancements will support the development of advanced endoluminal suturing devices that will feature data management capabilities and wireless connectivity, allowing the real-time monitoring of surgical metrics and device parameters, thus providing lucrative growth opportunities to the market.
The rising investments by various key market players in research and development will also support the development of technologically advanced endoluminal suturing devices. In 2022, Boston Scientific launched a state-of-the-art research and development center in Pune. The center provides expertise in diverse areas, including endoscopy, urology, cardiology, and neuromodulation, among others.
North America Holds Significant Share of the Market
The presence of a well-established healthcare infrastructure, the increasing requirement for surgical procedures, and the strong placement of various leading market players are some of the factors supporting the growth of the North America endoluminal suturing devices market. The growth of the market in the region can also be attributed to the introduction of favorable reimbursement policies and the availability of a large patient pool. The demand for minimally invasive procedures is also increasing in countries such as Canada and the United States, as they reduce the risk of infection, blood loss, scarring, and time of recovery. Endoluminal suturing devices allow surgeons to internally perform suturing with smaller incisions, playing an essential role in such procedures. The rise in the number of bariatric procedures in the region is further boosting the expansion of the market in North America. According to the estimates of the American Society for Metabolic and Bariatric Surgery, the total number of bariatric surgeries conducted in 2022 was 279,967.
Gastrointestinal Surgery Dominates the Market
The rising requirement for gastrointestinal surgeries can be attributed to the increasing occurrence of gastrointestinal perforations, severe acid reflux, inflammatory bowel disease, and gastrointestinal cancer. According to the estimates of the International Agency for Research on Cancer, gastrointestinal cancer accounts for one in three cancer related deaths and one in four cancer cases across the globe.
Gastrointestinal perforations occur because of surgical complications, ulcers, and trauma. The endoluminal suturing devices are used for closing these perforations in order to prevent the leakage of gastric contents in the abdominal cavity. Therefore, the availability of effective endoluminal suturing devices is essential for the proper management of gastrointestinal perforations. Endoluminal suturing devices also allow surgeons to endoscopically close leaks that can occur at the site of anastomosis after gastrointestinal surgeries, avoiding the requirement for additional invasive surgeries.
Hospitals Account for a Significant Global Endoluminal Suturing Devices Market Share
The segment expansion is supported by the increased requirement for surgical procedures in various regions across the globe. The rising demand for surgical procedures can be attributed to the growing prevalence of chronic health diseases that require surgical procedures for further exploration of the condition in order to give an appropriate diagnosis. These procedures also help in treating various pathological conditions, such as malignancy, trauma, and injury. The rising investments by various hospitals to meet evolving patient requirements and provide advanced medical care is another major factor bolstering the demand for endoluminal suturing devices from hospitals. In April 2024, the construction of UCSF Health Helen Diller Hospital was initiated. The hospital is expected to cost USD 4.3 billion and will have 15 stories. The design of this new hospital will integrate care and advanced science to provide a healing habitat for the patients. The facility will have the latest technologies in diagnostics, robotics, and surgical procedures. The construction of such state-of-the-art facilities in this evolving landscape of healthcare is a testament to the commitment provided by the sector to support the advancement of patient care.
Future Market Scenario (2024-2031F)
According to the global endoluminal suturing devices market analysis, the market is anticipated to witness significant growth over the forecast period 2024-2031. This growth can be attributed to expanding healthcare sector, rising investments in research and development activities, and increasing prevalence of various health conditions such as gastrointestinal perforations, severe acid reflux, inflammatory bowel disease, and gastrointestinal cancer. The increasing collaborations between healthcare providers and medical device manufacturers will drive innovation, supporting the development of advanced endoluminal devices and boosting the expansion of the market.
Key Players Landscape and Outlook
The key players of the endoluminal suturing devices market include Apollo Endosurgery, Inc. (Boston Scientific Corporation), B. Braun SE, Medtronic plc, Johnson & Johnson, and Cook Medical. The expansion of the market is supported by increasing investments in research and development activities, collaborations, and successful mergers and acquisitions.
In 2023, Boston Scientific successfully completed the acquisition of Apollo Endosurgery. Apollo's product portfolio includes different devices required in endoluminal surgery procedures. The endoluminal surgery procedures aid in managing gastrointestinal complications and close gastrointestinal defects. These procedures are also employed due to their less-invasive nature as opposed to laparoscopic and open surgeries. With the closure of this acquisition, the companies aim to provide a comprehensive suite of endobariatric and endoluminal surgery solutions to their patients.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work